Ibogaine: A Miracle Psychedelic?
Summary
Science Vs investigates Ibogaine, a psychedelic drug gaining attention for treating opioid addiction and PTSD. Hosts Wendy Zuckerman and Meryl Horn interview users who report profound relief from cravings, alongside experts discussing the drug’s potential to promote neuroplasticity. However, the episode highlights significant risks, including fatal heart arrhythmias, and notes that rigorous clinical trials have shown mixed results compared to placebos. Ultimately, the hosts advise caution, suggesting safer, regulated alternatives like psilocybin therapy over unproven Ibogaine clinics.
Topics discussed
Intro: Ibogaine hype, Rhett's opioid addiction story, and the intense trip experience
What is Ibogaine? Origins, traditional use, and brain mechanisms
Research on opioid addiction: Alan Davis's study and Rhett's recovery
Holly's story, neurogenesis, and how Ibogaine rewires the brain
Long-term efficacy, relapse rates, and the role of maintenance doses
Limitations of current research and lack of placebo-controlled trials
Safety risks: Heart arrhythmias, deaths, and failed noribogaine trials
Reckless dosing in studies and the combination with DMT
Expert advice: Risks vs. benefits and safer alternatives like psilocybin
Outro: Listener Q&A, citations, and credits
Listen ad-free on Castria